Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well anastrozole and letrozole after surgery work in treating
patients with stage I-III breast cancer. Drugs, such as anastrozole and letrozole, may stop
the growth of tumor cells by decreasing the amount of estrogen made by the body. Giving
anastrozole and letrozole after surgery may prevent breast cancer from coming back
(recurrence).